{"entity":{"type":"insider","cik":"0001595117","url":"/insider/0001595117","json_url":"/insider/0001595117.json","name":"George Simeon","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":39,"n_filings":19,"first":"2014-02-11","last":"2026-05-11","span_basis":"filed_date"},"name_variants":[{"name":"George Simeon","source":"filing","n_filings":19,"first_seen":"2014-02-11","last_seen":"2026-05-11"}],"transactions":[{"id":5785244,"accession":"0001193125-26-217656","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001193125-26-217656","line_url":"/filing/0001193125-26-217656","is_derivative":false,"issuer_cik":"0001595117","issuer_name":"Odyssey Therapeutics, Inc.","issuer_ticker":"ODTX","issuer_name_source":null,"issuer_url":"/issuer/0001595117","owner_cik":null,"owner_name":"George Simeon; SR ONE CAPITAL MANAGEMENT, LLC","owner_display_name":"George Simeon","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1780.0,"shares_display":"1,780","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":32040.0,"total_display":"32,040.00","total_whole":"32,040","shares_owned_after":1609161.0,"shares_owned_after_display":"1,609,161","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-11","filed_date":"2026-05-11","scope":"insider","n_lines":3},{"id":5785238,"accession":"0001193125-26-217656","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001193125-26-217656","line_url":"/filing/0001193125-26-217656","is_derivative":false,"issuer_cik":"0001595117","issuer_name":"Odyssey Therapeutics, Inc.","issuer_ticker":"ODTX","issuer_name_source":null,"issuer_url":"/issuer/0001595117","owner_cik":null,"owner_name":"George Simeon; SR ONE CAPITAL MANAGEMENT, LLC","owner_display_name":"George Simeon","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":555555.0,"shares_display":"555,555","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":9999990.0,"total_display":"9,999,990.00","total_whole":"9,999,990","shares_owned_after":1831383.0,"shares_owned_after_display":"1,831,383","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-11","filed_date":"2026-05-11","scope":"insider","n_lines":3},{"id":5810042,"accession":"0001193125-26-201887","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193125-26-201887","line_url":"/filing/0001193125-26-201887","is_derivative":false,"issuer_cik":"0001540171","issuer_name":"Avalyn Pharma Inc.","issuer_ticker":"AVLN","issuer_name_source":null,"issuer_url":"/issuer/0001540171","owner_cik":null,"owner_name":"George Simeon; SR ONE CAPITAL MANAGEMENT, LLC","owner_display_name":"George Simeon","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":555555.0,"shares_display":"555,555","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":9999990.0,"total_display":"9,999,990.00","total_whole":"9,999,990","shares_owned_after":2186562.0,"shares_owned_after_display":"2,186,562","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-01","filed_date":"2026-05-01","scope":"insider","n_lines":2},{"id":4202093,"accession":"0001193125-25-239153","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-239153","line_url":"/filing/0001193125-25-239153","is_derivative":false,"issuer_cik":"0001595117","issuer_name":"Zenas BioPharma, Inc.","issuer_ticker":"ZBIO","issuer_name_source":null,"issuer_url":"/issuer/0001595117","owner_cik":null,"owner_name":"George Simeon; SR ONE CAPITAL MANAGEMENT, LLC","owner_display_name":"George Simeon","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":126315.0,"shares_display":"126,315","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":2399985.0,"total_display":"2,399,985.00","total_whole":"2,399,985","shares_owned_after":1173395.0,"shares_owned_after_display":"1,173,395","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-09","filed_date":"2025-10-14","scope":"insider","n_lines":2},{"id":4947454,"accession":"0000950170-25-096666","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-096666","line_url":"/filing/0000950170-25-096666","is_derivative":false,"issuer_cik":"0001595117","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001595117","owner_cik":"0001595117","owner_name":"George Simeon","owner_display_name":"George Simeon","owner_url":"/insider/0001595117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":989812.0,"shares_display":"989,812","price_per_share":52.03,"price_display":"52.03","price_state":"stated","total_value":51499918.36,"total_display":"51,499,918.36","total_whole":"51,499,918","shares_owned_after":1730179.0,"shares_owned_after_display":"1,730,179","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-07-16","filed_date":"2025-07-17","scope":"insider","n_lines":3},{"id":2082962,"accession":"0000950170-24-106978","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950170-24-106978","line_url":"/filing/0000950170-24-106978","is_derivative":false,"issuer_cik":"0001595117","issuer_name":"Zenas BioPharma, Inc.","issuer_ticker":"ZBIO","issuer_name_source":null,"issuer_url":"/issuer/0001595117","owner_cik":null,"owner_name":"George Simeon; SR ONE CAPITAL MANAGEMENT, LLC","owner_display_name":"George Simeon","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2235294.0,"shares_display":"2,235,294","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":37999998.0,"total_display":"37,999,998.00","total_whole":"37,999,998","shares_owned_after":1854738.0,"shares_owned_after_display":"1,854,738","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-16","filed_date":"2024-09-16","scope":"insider","n_lines":3},{"id":2416248,"accession":"0000950170-24-038089","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-038089","line_url":"/filing/0000950170-24-038089","is_derivative":false,"issuer_cik":"0001595117","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001595117","owner_cik":"0001595117","owner_name":"George Simeon","owner_display_name":"George Simeon","owner_url":"/insider/0001595117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000000.0,"shares_display":"2,000,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":20000000.0,"total_display":"20,000,000.00","total_whole":"20,000,000","shares_owned_after":1548341.0,"shares_owned_after_display":"1,548,341","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-27","filed_date":"2024-03-28","scope":"insider","n_lines":2},{"id":7817040,"accession":"0001209191-23-056920","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-056920","line_url":"/filing/0001209191-23-056920","is_derivative":false,"issuer_cik":"0001595117","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001595117","owner_cik":null,"owner_name":"George Simeon; SR One Capital Fund I Aggregator LP; SR ONE CAPITAL PARTNERS I, LP; SR One Co-Invest I, LLC; SR One Co-Invest I Manager, LLC; SR ONE CAPITAL MANAGEMENT, LLC","owner_display_name":"George Simeon","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":609163.0,"shares_display":"609,163","price_per_share":0.6065,"price_display":"0.61","price_state":"stated","total_value":369457.3595,"total_display":"369,457.36","total_whole":"369,457","shares_owned_after":4391536.0,"shares_owned_after_display":"4,391,536","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-27","filed_date":"2023-11-29","scope":"insider","n_lines":2},{"id":7897826,"accession":"0001209191-23-029610","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-029610","line_url":"/filing/0001209191-23-029610","is_derivative":false,"issuer_cik":"0001595117","issuer_name":"Arcellx, Inc.","issuer_ticker":"ACLX","issuer_name_source":null,"issuer_url":"/issuer/0001595117","owner_cik":null,"owner_name":"SR One Co-Invest II Manager, LLC; George Simeon; SR One Capital Fund I Aggregator LP; SR ONE CAPITAL PARTNERS I, LP; SR One Co-Invest II, LLC; SR ONE CAPITAL MANAGEMENT, LLC","owner_display_name":"SR One Co-Invest II Manager, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1012833.0,"shares_display":"1,012,833","price_per_share":45.01168242938372,"price_display":"45.01","price_state":"stated","total_value":45589317.35,"total_display":"45,589,317.35","total_whole":"45,589,317","shares_owned_after":2834879.0,"shares_owned_after_display":"2,834,879","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-11","filed_date":"2023-05-15","scope":"insider","n_lines":4},{"id":6498099,"accession":"0001209191-22-062227","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-062227","line_url":"/filing/0001209191-22-062227#line-3","is_derivative":false,"issuer_cik":"0001595117","issuer_name":"Design Therapeutics, Inc.","issuer_ticker":"DSGN","issuer_name_source":null,"issuer_url":"/issuer/0001595117","owner_cik":"0001595117","owner_name":"George Simeon","owner_display_name":"George Simeon","owner_url":"/insider/0001595117","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":8.1358,"price_display":"8.14","price_state":"stated","total_value":325432.0,"total_display":"325,432.00","total_whole":"325,432","shares_owned_after":6526476.0,"shares_owned_after_display":"6,526,476","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2022-12-20","scope":"insider"},{"id":6498098,"accession":"0001209191-22-062227","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-062227","line_url":"/filing/0001209191-22-062227#line-2","is_derivative":false,"issuer_cik":"0001595117","issuer_name":"Design Therapeutics, Inc.","issuer_ticker":"DSGN","issuer_name_source":null,"issuer_url":"/issuer/0001595117","owner_cik":"0001595117","owner_name":"George Simeon","owner_display_name":"George Simeon","owner_url":"/insider/0001595117","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":360000.0,"shares_display":"360,000","price_per_share":8.6336,"price_display":"8.63","price_state":"stated","total_value":3108096.0,"total_display":"3,108,096.00","total_whole":"3,108,096","shares_owned_after":6486476.0,"shares_owned_after_display":"6,486,476","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-19","filed_date":"2022-12-20","scope":"insider"},{"id":6498095,"accession":"0001209191-22-062227","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-062227","line_url":"/filing/0001209191-22-062227#line-1","is_derivative":false,"issuer_cik":"0001595117","issuer_name":"Design Therapeutics, Inc.","issuer_ticker":"DSGN","issuer_name_source":null,"issuer_url":"/issuer/0001595117","owner_cik":"0001595117","owner_name":"George Simeon","owner_display_name":"George Simeon","owner_url":"/insider/0001595117","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":8.2811,"price_display":"8.28","price_state":"stated","total_value":4140550.0,"total_display":"4,140,550.00","total_whole":"4,140,550","shares_owned_after":6126476.0,"shares_owned_after_display":"6,126,476","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-16","filed_date":"2022-12-20","scope":"insider"},{"id":6779465,"accession":"0001209191-22-026258","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-026258","line_url":"/filing/0001209191-22-026258","is_derivative":false,"issuer_cik":"0001595117","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001595117","owner_cik":"0001595117","owner_name":"George Simeon","owner_display_name":"George Simeon","owner_url":"/insider/0001595117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1333333.0,"shares_display":"1,333,333","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":19999995.0,"total_display":"19,999,995.00","total_whole":"19,999,995","shares_owned_after":666667.0,"shares_owned_after_display":"666,667","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-28","filed_date":"2022-04-29","scope":"insider","n_lines":2},{"id":6693285,"accession":"0001209191-22-008281","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-22-008281","line_url":"/filing/0001209191-22-008281","is_derivative":false,"issuer_cik":"0001595117","issuer_name":"Arcellx, Inc.","issuer_ticker":"ACLX","issuer_name_source":null,"issuer_url":"/issuer/0001595117","owner_cik":null,"owner_name":"George Simeon; SR One Capital Fund I Aggregator LP; SR One Co-Invest II Manager, LLC; SR ONE CAPITAL PARTNERS I, LP; SR One Co-Invest II, LLC; SR ONE CAPITAL MANAGEMENT, LLC","owner_display_name":"George Simeon","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1666667.0,"shares_display":"1,666,667","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":25000005.0,"total_display":"25,000,005.00","total_whole":"25,000,005","shares_owned_after":2033196.0,"shares_owned_after_display":"2,033,196","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-08","filed_date":"2022-02-10","scope":"insider","n_lines":2},{"id":4178891,"accession":"0001209191-21-024233","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-024233","line_url":"/filing/0001209191-21-024233#line-3","is_derivative":false,"issuer_cik":"0001595117","issuer_name":"Design Therapeutics, Inc.","issuer_ticker":"DSGN","issuer_name_source":null,"issuer_url":"/issuer/0001595117","owner_cik":"0001595117","owner_name":"George Simeon","owner_display_name":"George Simeon","owner_url":"/insider/0001595117","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":5626476.0,"shares_owned_after_display":"5,626,476","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-30","filed_date":"2021-04-01","scope":"insider"},{"id":2337665,"accession":"0001209191-20-032147","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-032147","line_url":"/filing/0001209191-20-032147#line-1","is_derivative":false,"issuer_cik":"0001595117","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595117","owner_cik":"0001595117","owner_name":"George Simeon","owner_display_name":"George Simeon","owner_url":"/insider/0001595117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":83333.0,"shares_display":"83,333","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":4999980.0,"total_display":"4,999,980.00","total_whole":"4,999,980","shares_owned_after":2253660.0,"shares_owned_after_display":"2,253,660","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-21","filed_date":"2020-05-26","scope":"insider"},{"id":8206878,"accession":"0001209191-19-053771","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-053771","line_url":"/filing/0001209191-19-053771#line-1","is_derivative":false,"issuer_cik":"0001510487","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001510487","owner_cik":"0001595117","owner_name":"George Simeon","owner_display_name":"George Simeon","owner_url":"/insider/0001595117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":357142.0,"shares_display":"357,142","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":9999976.0,"total_display":"9,999,976.00","total_whole":"9,999,976","shares_owned_after":2982855.0,"shares_owned_after_display":"2,982,855","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-18","filed_date":"2019-10-22","scope":"insider"},{"id":8647325,"accession":"0001209191-19-049226","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-049226","line_url":"/filing/0001209191-19-049226#line-1","is_derivative":false,"issuer_cik":"0001595117","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595117","owner_cik":"0001595117","owner_name":"George Simeon","owner_display_name":"George Simeon","owner_url":"/insider/0001595117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":177777.0,"shares_display":"177,777","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":7999965.0,"total_display":"7,999,965.00","total_whole":"7,999,965","shares_owned_after":2170327.0,"shares_owned_after_display":"2,170,327","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-10","filed_date":"2019-09-11","scope":"insider"},{"id":8344945,"accession":"0001209191-19-025789","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-025789","line_url":"/filing/0001209191-19-025789#line-3","is_derivative":false,"issuer_cik":"0001595117","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595117","owner_cik":"0001595117","owner_name":"George Simeon","owner_display_name":"George Simeon","owner_url":"/insider/0001595117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":325000.0,"shares_display":"325,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":5850000.0,"total_display":"5,850,000.00","total_whole":"5,850,000","shares_owned_after":1992550.0,"shares_owned_after_display":"1,992,550","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-22","filed_date":"2019-04-24","scope":"insider"},{"id":6296086,"accession":"0001209191-18-051833","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-18-051833","line_url":"/filing/0001209191-18-051833#line-6","is_derivative":false,"issuer_cik":"0001510487","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001510487","owner_cik":"0001595117","owner_name":"George Simeon","owner_display_name":"George Simeon","owner_url":"/insider/0001595117","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":270000.0,"shares_display":"270,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":4590000.0,"total_display":"4,590,000.00","total_whole":"4,590,000","shares_owned_after":2625713.0,"shares_owned_after_display":"2,625,713","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-09-18","filed_date":"2018-09-20","scope":"insider"},{"id":2236048,"accession":"0000903423-16-001321","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000903423-16-001321","line_url":"/filing/0000903423-16-001321#line-3","is_derivative":false,"issuer_cik":"0001595117","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001595117","owner_cik":"0001595117","owner_name":"George Simeon","owner_display_name":"George Simeon","owner_url":"/insider/0001595117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":66500.0,"shares_display":"66,500","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":931000.0,"total_display":"931,000.00","total_whole":"931,000","shares_owned_after":3220627.0,"shares_owned_after_display":"3,220,627","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-24","filed_date":"2016-10-26","scope":"insider"},{"id":7100614,"accession":"0001179110-14-002551","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-14-002551","line_url":"/filing/0001179110-14-002551#line-4","is_derivative":false,"issuer_cik":"0001457612","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001457612","owner_cik":"0001595117","owner_name":"George Simeon","owner_display_name":"George Simeon","owner_url":"/insider/0001595117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":143773.0,"shares_display":"143,773","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":1725276.0,"total_display":"1,725,276.00","total_whole":"1,725,276","shares_owned_after":143773.0,"shares_owned_after_display":"143,773","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-02-10","filed_date":"2014-02-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":18,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001882782","name":"Odyssey Therapeutics, Inc.","url":"/issuer/0001882782","role":"Ten percent owner","n_filings":1,"first_seen":"2026-05-11","last_seen":"2026-05-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001540171","name":"Avalyn Pharma Inc.","url":"/issuer/0001540171","role":"Ten percent owner","n_filings":1,"first_seen":"2026-05-01","last_seen":"2026-05-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001953926","name":"Zenas BioPharma, Inc.","url":"/issuer/0001953926","role":"Ten percent owner","n_filings":2,"first_seen":"2024-09-16","last_seen":"2025-10-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001674416","name":"CRISPR Therapeutics AG","url":"/issuer/0001674416","role":"Director","n_filings":2,"first_seen":"2016-10-26","last_seen":"2025-07-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001787400","name":"Nkarta, Inc.","url":"/issuer/0001787400","role":"Director","n_filings":2,"first_seen":"2022-04-29","last_seen":"2024-03-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001828522","name":"eFFECTOR Therapeutics, Inc.","url":"/issuer/0001828522","role":"Ten percent owner","n_filings":1,"first_seen":"2023-11-29","last_seen":"2023-11-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001786205","name":"Arcellx, Inc.","url":"/issuer/0001786205","role":"Ten percent owner","n_filings":2,"first_seen":"2022-02-10","last_seen":"2023-05-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001807120","name":"Design Therapeutics, Inc.","url":"/issuer/0001807120","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2021-04-01","last_seen":"2022-12-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001595893","name":"Turning Point Therapeutics, Inc.","url":"/issuer/0001595893","role":"Director","n_filings":3,"first_seen":"2019-04-24","last_seen":"2020-05-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001510487","name":"Principia Biopharma Inc.","url":"/issuer/0001510487","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2018-09-20","last_seen":"2019-10-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001457612","name":"GENOCEA BIOSCIENCES, INC.","url":"/issuer/0001457612","role":"Director","n_filings":1,"first_seen":"2014-02-11","last_seen":"2014-02-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001595117","retrieved_at":"2026-08-22T22:44:40+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}